that human dendritic cells infected with MTB exhibit redistribution and decreased surface expression of heterodimeric α/β integrins that contain CD18 (β2). This decrease is not recovered in infected cells
with Mtb the ability to impair dendritic cell (DC) migration by limiting expression of heterodimeric integrins that contain CD18 (β2). This delays initiation of an adaptive immune response
targeted therapy. We identified and characterized RNA aptamers targeting integrin α5β1. This αβ heterodimeric cell-surface receptor is implicated in tumour angiogenesis and solid tumor aggressiveness. In glioblastoma…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.